Post by icemandios on Jan 7, 2020 0:45:55 GMT
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
THE WOODLANDS, Texas, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference:
38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 7:30 a.m. PST in San Francisco, CA.
About Lexicon Pharmaceuticals
THE WOODLANDS, Texas, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference:
38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2020 at 7:30 a.m. PST in San Francisco, CA.
A live audio webcast for this conference will be available in the “Events” section of the Lexicon website at www.lexpharma.com/. An archived version of the webcast will be available on the website for two weeks.
Lexicon is a fully integrated biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through its Genome5000™ program, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. In addition to its first commercial product, XERMELO, Lexicon has a pipeline of promising drug candidates in clinical and preclinical development in diabetes and metabolism, oncology and neuropathic pain. For additional information, please visit www.lexpharma.com.